Survivin antiapoptotic gene expression as a prognostic factor in non-small cell lung cancer: In situ hybridization study

Folia Histochemica et Cytobiologica

Volumn 43, Issue 4, 2005, Pages 237-242

  Karczmarek Borowska, B ^a   Filip, A ^b   Wojcierowski, J ^b   Smolen A ^b   Pilecka, I ^b   Jablonka A ^b  

^a Oncological Centre of Lublin Region   (Poland)

^b MEDICAL UNIVERSITY OF LUBLIN   (Poland)

Author keywords

In situ hybridization; Non small cell lung cancer; Survivin

Indexed keywords

CISPLATIN; ETOPOSIDE; MESSENGER RNA; SURVIVIN;

ADULT; AGED; APOPTOSIS; ARTICLE; CANCER CLASSIFICATION; CANCER COMBINATION CHEMOTHERAPY; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CELL DIFFERENTIATION; CONTROLLED STUDY; DRUG RESPONSE; FEMALE; GENE OVEREXPRESSION; HUMAN; HUMAN TISSUE; IN SITU HYBRIDIZATION; KAPLAN MEIER METHOD; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; PROGNOSIS; STATISTICAL ANALYSIS; STATISTICAL MODEL;

EID: 27744447437     PISSN: 02398508     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Adida C, Berrebi D, Peuchmaur M, Reyes-Mugica M, Altieri DC (1998) Anti-apoptosis gene, survivin, and prognosis of neuroblastoma. Lancet 351: 882-883
2. Adida C, Haioun C, Gaulard P, Lepage P, Briere J, Dombret H, Reyes F, Diebolt J, Gisselbret C, Salles G, Altieri DC, Molina TJ (2000) Prognostic significance of survivin expression in diffuse large B-cell lymphomas. Blood 96: 1921-1925
3. Ambrosini G, Adida C, Altieri AC (1997) A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma. Nat Med 3: 917-921
4. Ambrosini G, Adida C, Sirugo G, Altieri DC (1998) Induction of apoptosis and inhibition of cell proliferation by survivin gene targeting. J Biol Chem 273: 11177-11182
5. Dabrowski A, Filip A, Zgodzińki W, Dabrowska M, Polańska D, Wójcik M, Zinkiewicz K, Wallner G (2004) Assessment of prognostic significance of cytoplasmic survivin expression in advanced oesophageal cancer. Folia Histochem Cytobiol 42: 169-172
6. Escuin D, Rosell R (1999) The anti-apoptosis survivin gene and its role in human cancer: an overview. Clin Lung Cancer 1: 138-143
7. Falleni M, Pellegrini C, Marchetti A, Oprandi B, Buttitta F, Barassi F, Santambrogio L, Coggi G, Bosari S (2003) Survivin gene expression in early non-small cell lung cancer. J Pathol 200: 620-626
8. Gazzaniga P, Gradilone A, Guliani O, Gandini O, Silvestri I, Nofroni I, Saccani G, Frati L, Agliano AM (2003) Expression and prognostic significance of livin, survivin and other apoptosis-related genes in the progression of superficial bladder cancer. Ann Oncol 14: 85-90
9. Grabowski P, Künel T, Mühr-Wilkenshoff F, Heine B, Stein H, Höpfer M, Gremer CT, Scherübl H (2003) Prognostic value of nuclear survivin expression in oesophageal squamous cell carcinoma. Br J Cancer 88: 115-119
10. Islam A, Kageyama H, Takada N (2000) High expression of survivin, mapped 17q25, is significantly associated with poor prognostic factors and promotes cell survival in human neuroblastoma. Oncogene 19: 617-623
11. Kanwar JR, Shen WP, Kanwar RK, Berg RW, Krissansen GW (2001) Effects of survivin antagonists on growth of established tumors and B7-1 immunogene therapy. J Natl Cancer Inst 93: 1541-1552
12. Kato J, Kuwabara Y, Mitani M, Shinoda N, Sato A, Toyama T, Mitsui A, Nishiwaki T, Moriyama S, Kudo J, Fuji Y (2001) Expression of survivin in oesophageal cancer: correlation with the prognosis and response to chemotherapy. Int J Cancer 95: 92-95
13. Kaur P, Kallakury BS, Sheehan CE, Fisher HA, Kaufman RP (2004) Survivin and Bcl-2 expression in prostatic adenocarcinomas. Arch Pathol Lab Med 128: 39-43
14. Kawasaki H, Altieri DC, Lu C-D, Toyoda M, Tenjo T, Tanigawa N (1998) Inhibition of apoptosis by survivin predicts shorter survival rates in colorectal cancer. Cancer Res 58: 5071-5074
15. Krishna M, Lloyd RV, Batts KP (1997) Detection of albumin messenger RNA in hepatic and extrahepatic neoplasms. A marker of hepatocellular differentiation. Am J Surg Pathol 21: 147-152
16. Lee JH, Lee DH, Park SS, Seok SE, Lee JD (1988) Oncogene expression detected by in situ hybridization in human primary lung cancer. Chest 94: 1046-1049
17. Lu C-D, Altieri DC, Tanigawa N (1998) Expression of a novel antiapoptosis gene, survivin, correlated with tumor cell apoptosis and p53 accumulation in gastric carcinomas. Cancer Res 58: 1808-1812
18. Monzo M, Rosell R, Felip E, Astudillo J, Sanchez JJ, Maestre J, Martin C, Font A, Barnadas A, Abad A (1999) A novel anti-apoptosis gene: re-expression of survivin messenger RNA as a prognosis marker in non-small-cell lung cancers. J Clin Oncol 17: 2100-2104
19. Mountain CF (1997) Revisions in the international system for staging lung cancer. Chest 111: 1710-1717
20. Olie RA, Simes-Wüst P, Baumann B, Leech SH, Fabbro D, Stahel RA, Zangemeister-Witke U (2000) A novel antisense oligonucleotide targeting survivin expression induces apoptosis and sensitizes lung cancer cells to chemotherapy. Cancer Res 60: 2805-2809
21. Tamm I, Wang Y, Sausville E, Scudiero DA, Vigna N, Oltersdorf T, Reed JC (1998) IAP-family protein survivin inhibits caspase activity and apoptosis induced by Fas (CD95), Bax, caspases, and anticancer drugs. Cancer Res 58: 5315-5320
22. Tanabe H,Yagihashi A, Tsuji N, Shijubo Y, Abe S, Watanabe N (2004) Expression of survivin mRNA and livin mRNA in non-small-cell lung cancer. Lung Cancer 46: 299-304
23. Tanaka K, Iwamoto S, Gon G, Nohara T, Iwamoto M, Tanigawa N (2000) Expression of survivin and its relationship to loss of apoptosis in breast carcinomas. Clin Cancer Res 6: 127-134
24. Trieb K, Lehner R, Stulnig T, Sulzbacher I, Shroyer KR (2003) Survivin expression in human osteosarcoma is a marker for survival. Eur J Surg Oncol 29: 379-382